GH Research (FRA:1KA) FFO


FRA:1KA GH Research PLC FRA:1KA
35 GF Score
Price €21.20
! 2 Warning Signs
View Full Analysis

What is GH Research FFO?

FFO (Funds from operations) only applies to REITs.

FRA:1KA
35GF Score
GH Research PLC FRA:1KA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GH Research Business Description

Other Exchanges GHRS:USA
Address Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
35GF Score

Get the complete analysis for FRA:1KA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.20
Price